Concepedia

Anish Mehta

AM

42

Publications

2.2K

Citations

24

H-Index

1976

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

M.S. Ramaiah Medical College

Thomas Jefferson University

Anish Mehta is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, neurology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1976–2021

42

Publications

42

Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials

Kristian Reich, Kim Papp, Andrew Blauvelt et al. · The Lancet · 2017 · 540 citations

, , +6

Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial

Kim Papp, Diamant Thaçi, Kristian Reich et al. · British Journal of Dermatology · 2015 · 265 citations · Full text

Clinical improvement in psoriasis with specific targeting of interleukin-23

Tamara Kopp, Elisabeth Riedl, Christine Bangert et al. · Nature · 2015 · 205 citations

, , +5

Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis

Jean‐Yves Reginster, K. Malmström, Anish Mehta et al. · Annals of the Rheumatic Diseases · 2006 · 67 citations · Full text

Effect of montelukast for treatment of asthma in cigarette smokers

David Price, Todor A. Popov, Leif Bjermer et al. · Journal of Allergy and Clinical Immunology · 2013 · 65 citations

, , +7

Rows per page

1–5 of 42